Best Nanotechnology Stocks Worth Watching - January 10th

3 Chip Stocks Approaching Buy Points Onto Innovation, Nano Dimension, NVE, and Clene are the five Nanotechnology stocks to watch today, according to MarketBeat's stock screener tool. Nanotechnology stocks are shares of companies that develop, manufacture, or commercialize products and services based on nanoscale materials, devices, or processes. For investors they are often viewed as speculative growth plays whose value depends on long-term scientific progress, commercialization and regulatory approval. These companies can span sectors such as healthcare, electronics, energy and advanced materials, and tend to be more volatile due to technical and market uncertainties. These companies had the highest dollar trading volume of any Nanotechnology stocks within the last several days.Get Onto Innovation alerts:Onto Innovation (ONTO)Onto Innovation Inc. engages in the design, development, manufacture, and support of process control tools that performs optical metrology. The company offers lithography systems and process control analytical software. It also offers process and yield management solutions, and device packaging and test facilities through standalone systems for optical metrology, macro-defect inspection, packaging lithography, and transparent and opaque thin film measurements.Read Our Latest Research Report on ONTONano Dimension (NNDM)Nano Dimension Ltd., together with its subsidiaries, engages in additive manufacturing solutions in Israel and internationally. The company offers 3D printers, comprising AME systems, which are inkjet printers, that produces Hi-PEDs by depositing proprietary conductive and dielectric substances, as well as integrates in-situ capacitors, antennas, coils, transformers, and electromechanical components; micro additive manufacturing systems, a digital light processing printers (DLP) that achieves production-grade polymer and composite parts; and industrial additive manufacturing systems, that utilizes a patented foil system that fabricates ceramic and metal parts.Read Our Latest Research Report on NNDMNVE (NVEC)NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data.Read Our Latest Research Report on NVECClene (CLNN)Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases.Read Our Latest Research Report on CLNNRead MoreMarketBeat's Top Five Stocks to Own in January 20263 Stocks Where Insiders Are Buying, Not BailingThese 3 Underrated ETFs Could Boom in 2026NVIDIA’s Next Leg Higher May Have Started at CESMarketBeat Week in Review – 01/05 - 01/09Warner Bros. Rejects Paramount's Offer—How It Affects WBD, NFLX, PSKYThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Onto Innovation Right Now?Before you consider Onto Innovation, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Onto Innovation wasn't on the list.While Onto Innovation currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here